2032eP Net treatment benefit in ARTEMIA trial comparing OSE2101 to docetaxel in patient with non-small cell lung cancer (NSCLC): Outcomes prioritization based on investigators preferences. - Piedbois, P.; Kosta, S.; Montestruc, F.; Buyse, M.E.; Salvaggio, S.; Cappuzzo, F.; Dziadziuszko, R.; Viteri, S.; Pierache, A.; Perot, S.; Comis, S.; Gabarre, V.; et al. (Annals of Oncology, 2025)